肾上腺增生与高血压诊治进展  

Advances in diagnosis and treatment of adrenal hyperplasia and hypertension

作　　者：赵振华[1] 胡卫列[1] 

机构地区：[1]广州军区广州总医院泌尿外科研究所,中国人民解放军泌尿外科中心,广东广州510010

出　　处：《实用医院临床杂志》2014年第4期22-25,共4页Practical Journal of Clinical Medicine

摘　　要：肾上腺增生是继发性高血压的重要原因之一,近年随着诊断水平的不断提高,肾上腺增生的检出率不断升高。原发性醛固酮增多症患者中60%以上为特发性肾上腺皮质增生,最近Sang等在一次关于中国人难治性高血压多中心流行病学调查研究中显示原发性醛固酮增多症占中国人难治性高血压人群的7.1%[1],人们已意识到肾上腺增生引起高血压的重要性。现就肾上腺性高血压的诊治的研究进展作一综述。Adrenal hyperplasia is an important cause of secondary hypertension.With the continuous improvement of the level of diagnosis,detection rate of adrenal hyperplasia was increased in recent years.More than 60% of patients with primary aldosteronism is idiopathic adrenal hyperplasia。Recently,Sang X et al reported that primary aldosteronism accounted 7.1% of Chinese refractory hypertension in a multi-center epidemiological investigation of Chinese refractory hypertension[1].People have been aware of the importance of hypertension caused by adrenal hyperplasia.The progress in studies of adrenal hypertension is reviewed.

关 键 词：肾上腺增生 高血压 诊治 

分 类 号：R586[医药卫生—内分泌] R544.1[医药卫生—内科学]